|
posters
New
Resistance Technologies and Interpretations
Comparison
of single-genome sequencing with standard genotype analysis
for detection of HIV-1 drug-resistance mutations
M Kearney
Drug-resistant
mutants of HIV-1 persist at higher concentrations in peripheral
blood mononuclear cells compared to plasma and are detected
at a higher rate by OLA compared to consensus sequencing
LM Frenkel
Reverse
transcription fitness assay by quantitative determination
of intermediate HIV-1 reverse transcription cDNA products
in PBMCs
M Nijhuis
Correlation
between Interpreted Genotype and Virtual Phenotype for predicting
drug resistance in HIV-1
O Gallego
Interpreting
resistance to lopinavir/ritonavir in HIV-1 subtype C patients
Z Grossman
Exploration
of methodology for estimating upper clinical breakpoints for
lopinavir/ritonavir by analysis of the emergence of resistance
during virological failure in experienced patients
RC Stevens
Clinically
relevant interpretation of genotype for resistance to ritonavir
(100 mg twice daily) plus saquinavir (800 mg twice daily)
in HIV-1-infected protease inhibitor-experienced patients
V Calvez
Exploring
the effects of adherence on resistance: use of local linear
regression to reveal relationships between adherence and resistance
in antiretroviral-naive patients treated with lopinavir/ritonavir
or nelfinavir
M King
Mutations
at reverse transcriptase codon 103: phenotypic resistance
to non-nucleoside reverse transcriptase inhibitor and clinical
correlates
PR Harrigan
Genotypic
associations with non-nucleoside reverse transcriptase inhibitor
susceptibility in circulating recombinant forms of HIV-1 strains
in North and South America
A Florance
Clinician
knowledge and attitudes towards genotypic testing
C Salama
|
